167 related articles for article (PubMed ID: 34755438)
1. Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa.
Reynolds Z; McCluskey SM; Moosa MYS; Gilbert RF; Pillay S; Aturinda I; Ard KL; Muyindike W; Musinguzi N; Masette G; Moodley P; Brijkumar J; Rautenberg T; George G; Johnson BA; Gandhi RT; Sunpath H; Marconi VC; Bwana MB; Siedner MJ
HIV Med; 2022 May; 23(5):474-484. PubMed ID: 34755438
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
[TBL] [Abstract][Full Text] [Related]
3. HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China.
Leng X; Liang S; Ma Y; Dong Y; Kan W; Goan D; Hsi JH; Liao L; Wang J; He C; Zhang H; Xing H; Ruan Y; Shao Y
BMJ Open; 2014 Oct; 4(10):e005886. PubMed ID: 25319999
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
5. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes.
Moorhouse M; Maartens G; Venter WDF; Moosa MY; Steegen K; Jamaloodien K; Fox MP; Conradie F
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):73-78. PubMed ID: 30334876
[TBL] [Abstract][Full Text] [Related]
6. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
Manasa J; Lessells RJ; Skingsley A; Naidu KK; Newell ML; McGrath N; de Oliveira T;
PLoS One; 2013; 8(8):e72152. PubMed ID: 23991055
[TBL] [Abstract][Full Text] [Related]
7. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.
Ndahimana Jd; Riedel DJ; Mwumvaneza M; Sebuhoro D; Uwimbabazi JC; Kubwimana M; Mugabo J; Mulindabigwi A; Kirk C; Kanters S; Forrest JI; Jagodzinski LL; Peel SA; Ribakare M; Redfield RR; Nsanzimana S
Trop Med Int Health; 2016 Jul; 21(7):928-35. PubMed ID: 27125473
[TBL] [Abstract][Full Text] [Related]
10. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.
Namale G; Kamacooko O; Bagiire D; Mayanja Y; Abaasa A; Kilembe W; Price M; Ssemwanga D; Lunkuse S; Nanyonjo M; Ssenyonga W; Mayaud P; Newton R; Kaleebu P; Seeley J
Sex Transm Infect; 2019 Sep; 95(6):405-411. PubMed ID: 31266818
[TBL] [Abstract][Full Text] [Related]
11. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
[TBL] [Abstract][Full Text] [Related]
12. Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa.
Rautenberg TA; Ng SK; George G; Moosa MS; McCluskey SM; Gilbert RF; Pillay S; Aturinda I; Ard KL; Muyindike WR; Musinguzi N; Masette G; Pillay M; Moodley P; Brijkumar J; Gandhi RT; Johnson B; Sunpath H; Bwana MB; Marconi VC; Siedner MJ
Health Qual Life Outcomes; 2023 Aug; 21(1):94. PubMed ID: 37605150
[TBL] [Abstract][Full Text] [Related]
13. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
[TBL] [Abstract][Full Text] [Related]
14. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
[TBL] [Abstract][Full Text] [Related]
15. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
[TBL] [Abstract][Full Text] [Related]
16. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
[TBL] [Abstract][Full Text] [Related]
18. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
[TBL] [Abstract][Full Text] [Related]
20. Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.
Baumann A; Musaazi J; Kambugu A; Kälin M; Weissberg D; Ssemwanga D; Fehr J; Castelnuovo B; Sekaggya-Wiltshire C; von Braun A
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):481-487. PubMed ID: 30633041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
